Impact of the Glycemic Control and Duration of Type 2 Diabetes on Vitamin D Level and Cardiovascular Disease Risk

Journal of Diabetes Research
Thuraya A AlaidarousMahmoud M A Abulmeaty

Abstract

To investigate the impact of glycemic control and T2D duration on vitamin D status and cardiovascular disease (CVD) risk among Saudi patients. This case-control study was conducted in King Faisal Specialist Hospital, Saudi Arabia. A total of 25 nondiabetic controls and 92 patients with confirmed T2D, aged 20-60 years, were included. Patients with T2D were divided into the following groups based on disease duration (newly diagnosed: ≈6 months and long duration: ≥5 years) and glycemic control based on their glycated hemoglobin (HbA1C) level with a threshold of ≤0.053 mol/mol: newly diagnosed controlled (NC, n = 25), newly diagnosed uncontrolled (NU, n = 25), newly diagnosed uncontrolled (NU, n = 25), newly diagnosed uncontrolled (NU, n = 25), newly diagnosed uncontrolled (NU. Our study showed that T2D duration was an independent predictor of vitamin D deficiency. The longer disease duration, the lower odds of being vitamin D deficient (odds ratio (OR) = 0.05, 95% CI: 0.01-0.29, p < 0.05). No significant association was observed between vitamin D and HbA1C levels. In the NU group, CVD risk scores were directly correlated with serum 25(OH)D (r = 0.53, p < 0.05). No significant association was observed between vitamin D and HbA1C le...Continue Reading

References

Apr 29, 2004·The American Journal of Clinical Nutrition·Ken C ChiuMohammed F Saad
Mar 29, 2007·The Journal of Clinical Endocrinology and Metabolism·Anastassios G PittasBess Dawson-Hughes
Jul 20, 2007·The New England Journal of Medicine·Michael F Holick
Jul 20, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Andries J Bakker, Matthias Mücke
Feb 1, 2008·Diabetes Care·Ian H de BoerUNKNOWN Women's Health Initiative Investigators
Apr 11, 2008·The American Journal of Clinical Nutrition·Michael F Holick, Tai C Chen
Jun 10, 2009·Circulation·Michael J PencinaRamachandran S Vasan
Jun 1, 2010·Endocrinology and Metabolism Clinics of North America·Tatiana TakiishiChantal Mathieu
Aug 8, 2012·Dermato-endocrinology·Bunyamin Yavuz, Derun Taner Ertugrul
Jun 25, 2013·Mayo Clinic Proceedings·Arash Hossein-nezhad, Michael F Holick
May 21, 2014·Journal of Diabetes Investigation·Jeong-Ah ShinHo-Young Son
Apr 19, 2015·BMC Endocrine Disorders·Jayesh J ShethRama Vaidya
Feb 2, 2016·The Journal of Clinical Endocrinology and Metabolism·Rolf JordeMoira Y S Hutchinson
Dec 10, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Paul LipsSuat Simsek
Dec 29, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Nasser M Al-Daghri
Feb 2, 2018·Journal of Family & Community Medicine·Haneen Al-AlyaniMir Sadat-Ali
Mar 7, 2018·BMC Endocrine Disorders·Khalid Al-RubeaanFahd I Al Rumaih
Mar 27, 2018·Journal of the Endocrine Society·Edith AngellottiAnastassios G Pittas
Sep 9, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Rıdvan SivritepeDamla Ortaboz
Jan 8, 2019·Journal of Family Medicine and Primary Care·Samiramiss GhavamBehrang Kazeminezhad

❮ Previous
Next ❯

Software Mentioned

SPSS
OpenEpi

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.